Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesDriving Behaviors Among Community-Dwelling Persons With Multiple Sclerosis
Archives of Physical Medicine and Rehabilitation, 06/22/09
Schultheis MT et al. - The current findings suggest that as disease severity progresses, differences in frequency of driving (days per week) and the use of self-limiting driving behaviors may vary. Furthermore, the findings also raise questions regarding the overall sensitivity of the most commonly used clinical driving assessment method (the behind-the-wheel evaluation) to accurately capture driving capacity in the milder stages of the disease process. The results indicate the need to consider issues related to driving as MS severity progresses, and, given the progressive nature of MS and the concerns of the validity of the most common clinical driving assessment measures (the behind-the-wheel evaluation), repeated assessment of driving ability may be the most effective approach for identifying driving difficulties among persons with MS.
Related Articles
Magnetic resonance imaging characteristics of children and adults with paediatric-onset multiple sclerosis
Brain, 11/25/09
Relevance Score: 69%
Increased cerebrospinal fluid chitotriosidase index in patients with multiple sclerosis
Acta Neurologica Scandinavica, 11/23/09
Relevance Score: 69%
APOE-epsilon4 is not associated with cognitive impairment in relapsing-remitting multiple sclerosis
Multiple Sclerosis, 11/19/09
Relevance Score: 69%
Cochlear implantation in a profoundly deaf patient who also suffers from multiple sclerosis - a case study
Cochlear Implants International, 10/27/09
Relevance Score: 69%
A single-centre, randomized, double-blind, placebo-controlled study of interferon beta-1b on primary progressive and transitional multiple sclerosis
Multiple Sclerosis, 10/01/09
Relevance Score: 69%
Today in Demyelinating Disorders...keeping you current
Receive free subspecialty "5-minute updates" via email
Psychosocial dysfunction in the first year after Guillain-Barré syndrome
Muscle & Nerve, 12/02/09
Multiple sclerosis in the Faroe Islands. 8. Notifiable diseases
Acta Neurologica Scandinavica, 12/02/09
Efficacy of thalidomide for the treatment of amyotrophic lateral sclerosis: A phase II open label clinical trial
Amyotrophic Lateral Sclerosis, 12/01/09
Sponsor
Article Search
Sponsor